MBTPS2 exacerbates albuminuria in streptozotocin-induced type I diabetic nephropathy by promoting endoplasmic reticulum stress-mediated renal damage

References

• Aten, E., et al., 2010. Keratosis Follicularis Spinulosa Decalvans is caused by mutations in MBTPS2. Human mutation, 31 (10), 1125–1133.
   PubMed Web of Science ®Google Scholar
• Ayala, P., et al., 2012. Attenuation of endoplasmic reticulum stress using the chemical chaperone 4-phenylbutyric acid prevents cardiac fibrosis induced by isoproterenol. Experimental and molecular pathology, 92 (1), 97–104.
   PubMed Web of Science ®Google Scholar
• Badal, S.S., et al., 2016. miR-93 regulates Msk2-mediated chromatin remodelling in diabetic nephropathy. Nature communications, 7 (1), 12076.
   PubMedGoogle Scholar
• Boels, M.G.S., et al., 2017. Systemic monocyte chemotactic protein-1 inhibition modifies renal macrophages and restores glomerular endothelial glycocalyx and barrier function in diabetic nephropathy. American journal of pathology, 187 (11), 2430–2440.
   PubMed Web of Science ®Google Scholar
• Borsting, E., et al., 2014. Tribbles homolog 3 attenuates mammalian target of rapamycin complex-2 signaling and inflammation in the diabetic kidney. Journal of the American society of nephrology, 25 (9), 2067–2078.
   PubMed Web of Science ®Google Scholar
• Cai, Y., et al., 2016. Interplay of endoplasmic reticulum stress and autophagy in neurodegenerative disorders. Autophagy, 12 (2), 225–244.
   PubMed Web of Science ®Google Scholar
• Cao, A.L., et al., 2016. Ursodeoxycholic acid and 4-phenylbutyrate prevent endoplasmic reticulum stress-induced podocyte apoptosis in diabetic nephropathy. Laboratory investigation, 96 (6), 610–622.
   PubMed Web of Science ®Google Scholar
• Chow, B.S., and Allen, T.J., 2015. Mouse models for studying diabetic nephropathy. Current protocols in mouse biology, 5 (2), 85–94.
   PubMedGoogle Scholar
• Cunard, R., and Sharma, K., 2011. The endoplasmic reticulum stress response and diabetic kidney disease. American journal of physiology-renal physiology, 300 (5), F1054–1061.
   PubMed Web of Science ®Google Scholar
• El Karoui, K., et al., 2016. Endoplasmic reticulum stress drives proteinuria-induced kidney lesions via Lipocalin 2. Nature communications, 7 (1), 10330.
   PubMedGoogle Scholar
• Facer, P., et al., 2007. Differential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathy. BMC neurology, 7 (1), 11.
   PubMedGoogle Scholar
• Fan, Y., et al., 2017. The role of endoplasmic reticulum stress in diabetic nephropathy. Current diabetes reports, 17 (3), 17.
   PubMed Web of Science ®Google Scholar
• Fan, Y., et al., 2015. RTN1 mediates progression of kidney disease by inducing ER stress. Nature communications, 6 (1), 7841.
   PubMedGoogle Scholar
• Furman, B.L., 2015. Streptozotocin-induced diabetic models in mice and rats. Current protocols in pharmacology, 70, 5.47.1–5.47.20.
   PubMedGoogle Scholar
• Gusella, G.L., et al., 2002. Lentiviral gene transduction of kidney. Human gene therapy, 13 (3), 407–414.
   PubMed Web of Science ®Google Scholar
• Hao, S., Bellner, L., and Ferreri, N.R., 2013. NKCC2A and NFAT5 regulate renal TNF production induced by hypertonic NaCl intake. American journal of physiology-renal physiology, 304 (5), F533–542.
   PubMed Web of Science ®Google Scholar
• Hetz, C., and Papa, F.R., 2018. The unfolded protein response and cell fate control. Molecular Cell, 69 (2), 169–181.
   PubMed Web of Science ®Google Scholar
• Inagi, R., 2010. Endoplasmic reticulum stress as a progression factor for kidney injury. Current opinion in pharmacology, 10 (2), 156–165.
   PubMed Web of Science ®Google Scholar
• Karali, E., et al., 2014. VEGF signals through ATF6 and PERK to promote endothelial cell survival and angiogenesis in the absence of ER stress. Molecular cell, 54 (4), 559–572.
   PubMed Web of Science ®Google Scholar
• Kars, M., et al., 2010. Tauroursodeoxycholic acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women. Diabetes, 59 (8), 1899–1905.
   PubMed Web of Science ®Google Scholar
• Lindenmeyer, M.T., et al., 2008. Proteinuria and hyperglycemia induce endoplasmic reticulum stress. Journal of the American society of nephrology, 19 (11), 2225–2236.
   PubMed Web of Science ®Google Scholar
• Lindert, U., et al., 2016. MBTPS2 mutations cause defective regulated intramembrane proteolysis in X-linked osteogenesis imperfecta. Nature communications, 7 (1), 11920.
   PubMedGoogle Scholar
• Lindholm, D., et al., 2017. Recent insights into the role of unfolded protein response in ER stress in health and disease. Frontiers in cell and developmental biology, 5, 48.
   PubMed Web of Science ®Google Scholar
• Luo, Z.F., et al., 2010. Effects of 4-phenylbutyric acid on the process and development of diabetic nephropathy induced in rats by streptozotocin: regulation of endoplasmic reticulum stress-oxidative activation. Toxicology and applied pharmacology, 246 (1-2), 49–57.
   PubMed Web of Science ®Google Scholar
• Lupachyk, S., et al., 2013. Endoplasmic reticulum stress plays a key role in the pathogenesis of diabetic peripheral neuropathy. Diabetes, 62 (3), 944–952.
   PubMed Web of Science ®Google Scholar
• Ma, Y., et al., 2002. Two distinct stress signaling pathways converge upon the CHOP promoter during the mammalian unfolded protein response. Journal of molecular biology, 318 (5), 1351–1365.
   PubMed Web of Science ®Google Scholar
• Madhusudhan, T., et al., 2015. Defective podocyte insulin signalling through p85-XBP1 promotes ATF6-dependent maladaptive ER-stress response in diabetic nephropathy. Nature communications, 6 (1), 6496.
   PubMedGoogle Scholar
• Madhusudhan, T., et al., 2012. Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes. Blood, 119 (3), 874–883.
   PubMed Web of Science ®Google Scholar
• Morton, J., et al., 2012. Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy: results of the ADVANCE study. Diabetes care, 35 (11), 2201–2206.
   PubMed Web of Science ®Google Scholar
• Mulec, H., et al., 1993. Cholesterol: a renal risk factor in diabetic nephropathy? American journal of kidney diseases, 22 (1), 196–201.
   PubMed Web of Science ®Google Scholar
• Nemer, G., et al., 2017. Understanding the phenotypic similarities between IFAP and Olmsted syndrome from a molecular perspective: the interaction of MBTPS2 and TRPV3. Archives of dermatological research, 309 (8), 637–643.
   PubMed Web of Science ®Google Scholar
• Oeffner, F., et al., 2009. IFAP syndrome is caused by deficiency in MBTPS2, an intramembrane zinc metalloprotease essential for cholesterol homeostasis and ER stress response. The American journal of human genetics, 84 (4), 459–467.
   PubMed Web of Science ®Google Scholar
• Oltean, S., et al., 2017. Diabetic nephropathy: novel molecular mechanisms and therapeutic avenues. Biomed research international, 2017, 1–1.
   Google Scholar
• Papadopoulou-Marketou, N., Chrousos, G.P., and Kanaka-Gantenbein, C., 2017. Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis. Diabetes/metabolism research and reviews, 33 (2), e2841.
   Web of Science ®Google Scholar
• Qi, W., et al., 2011. Attenuation of diabetic nephropathy in diabetes rats induced by streptozotocin by regulating the endoplasmic reticulum stress inflammatory response. Metabolism, 60 (5), 594–603.
   PubMed Web of Science ®Google Scholar
• Rosolowsky, E.T., et al., 2011. Risk for ESRD in type 1 diabetes remains high despite renoprotection. Journal of the American society of nephrology, 22 (3), 545–553.
   PubMed Web of Science ®Google Scholar
• Rosse, T., et al., 1998. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature, 391 (6666), 496–499.
   PubMed Web of Science ®Google Scholar
• Scott, R.P., and Quaggin, S.E., 2015. Review series: the cell biology of renal filtration. Journal of cell biology, 209 (2), 199–210.
   PubMed Web of Science ®Google Scholar
• Sieber, J., et al., 2010. Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids. American journal of physiology-renal physiology, 299 (4), F821–829.
   PubMed Web of Science ®Google Scholar
• Tervaert, T.W., et al., 2010. Pathologic classification of diabetic nephropathy. Journal of the American society of nephrology, 21 (4), 556–563.
   PubMed Web of Science ®Google Scholar
• Wu, H., et al., 2015. Metallothionein plays a prominent role in the prevention of diabetic nephropathy by sulforaphane via up-regulation of Nrf2. Free radical biology and medicine, 89, 431–442.
   PubMed Web of Science ®Google Scholar
• Ye, J., et al., 2000. ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Molecular cell, 6 (6), 1355–1364.
   PubMed Web of Science ®Google Scholar
• Zhuang, A., and Forbes, J.M., 2014. Stress in the kidney is the road to pERdition: is endoplasmic reticulum stress a pathogenic mediator of diabetic nephropathy? Journal of endocrinology, 222 (3), R97–111.
   PubMed Web of Science ®Google Scholar